28-08-2026 18:23 via medpagetoday.com

First Major Trial Win for Contemporary DOACs in Lower-Risk Afib

(MedPage Today) -- Emerging randomized data favored oral anticoagulation for lower-risk patients with atrial fibrillation (Afib), researchers found.
Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral...
Read more »